Praxis Precision Medicines 

Yahoo Finance • 16 days ago

Stocks Settle Lower as Weakness in Big Tech Weighs

The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.35%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.51%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.46%.  March E-mini S&P futures (ESH26) fell -0.34%, and Ma... Full story

Yahoo Finance • 16 days ago

Sector Update: Health Care Stocks Mixed in Late Afternoon Trading

Health care stocks were mixed late Monday afternoon, with the NYSE Health Care Index fractionally hi PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 16 days ago

Stocks Fall as Megacap Technology Stocks Slide and Metals Plunge

The S&P 500 Index ($SPX) (SPY) today is down -0.24%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.24%.  March E-mini S&P futures (ESH26) are down -0.28%, and March E-mini N... Full story

Yahoo Finance • 17 days ago

Stocks Slip Due to Weakness in Megacap Technology Stocks

The S&P 500 Index ($SPX) (SPY) today is down -0.24%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.24%.  March E-mini S&P futures (ESH26) are down -0.28%, and March E-mini N... Full story

Yahoo Finance • 17 days ago

Praxis rises on ulixacaltamide gaining Breakthrough Therapy status

[Multiple exposure elderly woman hand trembling, Neurological disorder, mental health, shaking hands closeup, anxiety and psychological health issue, psychiatry instability, dementia, Parkinson symptom] Victor Golmer/iStock via Getty Image... Full story

Yahoo Finance • 17 days ago

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential tremor Praxis remains on track to submit ulixacaltamide NDA in early 2026 based on recently completed... Full story

Yahoo Finance • 17 days ago

Stocks making the biggest moves premarket: DigitalBridge, Praxis Precision Medicines, Coupang & more

Check out the companies making headlines before the bell: DigitalBridge — The private equity firm that invests in data centers and other assets surged more than 32% after Bloomberg News, citing unnamed sources, said Japan's SoftBank is in... Full story

Yahoo Finance • last month

Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy

Clear recognition of high unmet need and urgency for the SCN2A community and plausibility of the mechanism of elsunersen FDA agreed to proposed changes to the EMBRAVE3 trial design to be a single-arm, baseline-controlled study Enrollment... Full story

Yahoo Finance • last month

7 Hidden Multibagger Stocks to Invest In

In this article, we will take a look at the top 7 hidden multibagger stocks to invest in. Multibaggers often take the limelight because of their stellar returns, but it isn’t always easy to catch these multibaggers while they are in the p... Full story

Yahoo Finance • last month

Top Midday Gainers

Praxis Precision Medicines (PRAX) reported positive trial results late Thursday of relutrigine to tr PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Stock Market Today: Nasdaq, Dow Gain As Consumer Sentiment Rises for First Time in Five Months

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Friday. This is TheStreet’s Stock Market Today for Dec. 5, 2025. You can... Full story

Yahoo Finance • last month

Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed

(RTTNews) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments. Sensei Biotherapeutics Inc. (SNSE) soared 62.9% to $17.20... Full story

Yahoo Finance • last month

Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Successful interim analysis triggered early stop for efficacy Topline study results to be shared at the American Epilepsy Society Annual Meeting on December 6, 2025 Praxis confirms an upcoming meeting with the FDA to discuss the result... Full story

Yahoo Finance • last month

Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor

BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorde... Full story

Yahoo Finance • last month

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorde... Full story

Yahoo Finance • 2 months ago

Praxis to present latest preclinical and clinical advancements across leading epilepsy portfolio at the 2025 American Epilepsy Society (AES) Annual Meeting

BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into therapies for central nervous system (CNS) disorders driven by neuron... Full story

Yahoo Finance • 2 months ago

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

BOSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorde... Full story

Yahoo Finance • 2 months ago

Praxis a new buy at BTIG as biotech is a top pick for 2026

[Wall Street New York stock exchange stock market] alexsl * BTIG has initiated Praxis Precision Medicines (PRAX [https://seekingalpha.com/symbol/PRAX]) with a buy rating saying that the central nervous system-focused biotech is a top pi... Full story

Yahoo Finance • 2 months ago

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorde... Full story

Yahoo Finance • 2 months ago

Praxis Precision Medicines GAAP EPS of -$3.36 beats by $0.11

* Praxis Precision Medicines press release [https://seekingalpha.com/pr/20294228-praxis-precision-medicines-provides-corporate-update-and-reports-third-quarter-2025-financial] (PRAX [https://seekingalpha.com/symbol/PRAX]): Q3 GAAP EPS of... Full story